The Black Market for Investigational GLP-1 Drugs

Podcast: JAMA Medical News · JAMA Network

Opublikowano: 2026-10-09

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content: Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain